Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Organogenesis Holdings (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Holdings’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), CytomX Therapeutics Inc (NASDAQ:CTMX), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Monopar Therapeutics Inc (NASDAQ:MNPR) and Altimmune Inc (NASDAQ:ALT).
Organogenesis Holdings has a consensus price target of $7.25.
The stock price for Organogenesis Holdings (NASDAQ: ORGO) is $4.78 last updated December 15, 2025 at 3:13 PM EST.
There are no upcoming dividends for Organogenesis Holdings.
Organogenesis Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Organogenesis Holdings.
Organogenesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.